N-PORT filing recap · July 2021

What did ARK Genomic Revolution ETF buy in July 2021?

Reported stock-position changes between this filing and the previous one. These are ARK Genomic Revolution ETF's own holdings, not the firm's.

Stock value

$8.57B

Positions

Estimated turnover

28.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

VERVVerve Therapeutics, Inc.$74.22Mreported value+1.25M shares QSIQuantum-Si Inc$71.31Mreported value+7.57M shares SMFRGenedx Holdings Corp$51.11Mreported value+4.53M shares CRBUCaribou Biosciences, Inc.$24.05Mreported value+1.48M shares DYNSDynamics Special Purpose Corp.$19.72Mreported value+2.00M shares DRNADicerna Pharmaceuticals Inc$11.83Mreported value+315.4K shares

Increased positions

PACBPacific Biosciences of California, Inc.$460.48Mreported value+474.0K shares+3.4%EXASExact Sciences Corporation$436.01Mreported value+327.0K shares+8.8%VRTXVertex Pharmaceuticals Inc / Ma$365.50Mreported value+78.4K shares+4.5%FATEFate Therapeutics, Inc.$357.38Mreported value

Reduced positions

TDOCTeladoc Health, Inc.$593.76Mreported value-24.9K shares-0.6%REGNRegeneron Pharmaceuticals, Inc.$393.61Mreported value-223.5K shares-24.6%CDNACaredx, Inc.$310.17Mreported value-811.8K shares-18.0%TWSTTwist Bioscience Corporation$303.79Mreported value-468.7K shares

Exited positions

GHGuardant Health, Inc.$112.86Mprior reported value-709.9K shares-100.0%TMOThermo Fisher Scientific Inc.$88.37Mprior reported value-187.9K shares-100.0%ABBVAbbvie Inc.$62.28Mprior reported value-558.6K shares-100.0%CMLFCm Life Sciences Inc$58.41Mprior reported value-4.31M shares